AI Biotech Researchers Relocate to Cambridge
A biotech company that’s received over $400 million from investors for its artificial intelligence-based research opens a new headquarters in Cambridge this week in a relocation from New York City.
Most Popular | Most Recent
- Unlocking Homeownership: Webster First FCU’s Guide to Mortgage Solutions
- Related Beal Closes on Financing for Vertex Lab Project
- Federal Reserve Declines to Cut Interest Rates, Cites Continued Inflation
- Boylston Street Property Trades for $39.1M
- Guv Appeals to Biz to Join Housing Fight
- Berkshire Bank to Close 3 CT Branches
- The B&T Daily: May 1, 2024
- Funding Secured for Multifamily Development in Wakefield
- Powell Likely to Signal Lower Inflation Is Needed Before Fed Will Cut Rates
- Wakefield Turns Down MBTA Communities Zoning
- Federal Regulators Adopt Proactive Stance Towards Stablecoins 3 views
- Pols Press Developer on Exchange South End Delays 2 views
- This Month in History: The Seaport Gets Its Transit Link 2 views
- A Man of Many Firsts 2 views
- Beltran Joins Sasaki As Director Of Business Development 2 views
- 2021: A Year of Seismic Change 2 views
- Developer Seeks Tax Break for New Amazon Offices 1 view
- Bank Holding Company Merger Brings Benefits 1 view
- Editorial Cartoon 1 view
- Women Leaders Offer Strategies for Success in Fintech 1 view